J&J Adds Unbranded Version of Stelara to 340B Contract Pharmacy Restrictions

J&J has added the unbranded version of its top-selling psoriatic arthritis treatment Stelara to its 340B contract pharmacy restrictions.
Johnson & Johnson (J&J) added Ustekinumab, the unbranded version of psoriatic arthritis treatment Stelara, to its 340B contract pharmacy restrictions [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a
Read More »

HHS Layoffs, Restructuring Don’t Appear to Have Affected 340B Yet, But Sources Say Program Could Move to CMS

The recent HHS restructuring has not had much of an impact on the 340B program, but that could change if the agency moves oversight of the program to CMS, sources said this week.
The Trump administration’s recent efforts to restructure the Department of Health and Human Services (HHS)—including division consolidations and the elimination [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a
Read More »

News Alert

Senate Confirms ‘Dr. Oz’ as CMS Administrator on Party-Line Vote

The U.S. Senate voted 53-45 along party lines Thursday to confirm Mehmet Oz as the new CMS administrator.
The U.S. Senate voted along party lines Thursday to confirm Mehmet Oz—a celebrity heart surgeon known as “Dr. Oz” for [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a
Read More »

Senate HELP Committee Asks RFK Jr. to Testify on HHS Reorganization Amid Mass Layoffs Including Up to One Third of HRSA Workforce

The Senate HELP Committee this week invited HHS Secretary Robert F. Kennedy Jr. to speak at an upcoming hearing on major restructuring at the Department of Health and Human Services, which included reportedly up to 600 layoffs at HRSA.
The leaders of a Senate panel that oversees several key federal health agencies this week invited Health and Human Services [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a
Read More »

Drugmakers, Kalderos Again Urge Federal Court to Support 340B Rebate Model; 340B Health, Hospitals Look to File Brief 

Three drugmakers, drug industry vendor Kalderos and 340B hospitals filed briefs with the U.S. District Court for the District of Columbia as part of 340B rebate legal challenges this week.
Three drugmakers that have sued the federal government to convert 340B discounts to a rebate model, and a drug industry [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a
Read More »

Genesis Health Care Launches Campaign Targeting NACHC’s ASAP 340B Partnership With PhRMA

340bVoice has launched a new campaign that takes aim at NACHC’s work with PhRMA as part of ASAP 340B.
340bVoice, the new advocacy arm of South Carolina-based health center Genesis Health Care, recently launched a five-figure, multi-state media campaign [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a
Read More »

In Apparent About-Face, HRSA Confirms Sagebrush’s 340B Eligibility During Federal Court Hearing

Sagebrush Health had sought emergency relief against the government to keep its clinic sites in the 340B program.
A federal judge yesterday delayed ruling on Sagebrush Health’s request for emergency relief after the government apparently reversed course and [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a
Read More »

U.S. Rep. Dusty Johnson: ‘No 340B Savings for Transgender Care Act’ Responds to Drug Industry’s Lies, Clarifies Savings’ Use 

U.S. Rep. Dusty Johnson (R-S.D.) told KSDN News that his “No 340B Savings for Transgender Care Act” responds to drug industry-backed efforts to undermine the 340B program.
The influential sponsor of a GOP U.S. House bill that would prohibit covered entities from using 340B savings on gender-affirming [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a
Read More »

Second Sight Solutions’ Parent Company Targeted in Cyber Attack, Firm Says 340B Platforms Do Not Appear to Have Been Affected

Berkeley Research Group, the parent company of Second Sight Solutions, which runs both 340B ESP and Beacon Channel Management, was targeted in an early March cyberattack.
The parent company of Second Sight Solutions, which runs both contract pharmacy claims clearinghouse vendor 340B ESP and new 340B [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a
Read More »

Trump-Aligned Think Tank Proposes Lowering U.S. Drug Prices Through IRA and Other Policies, Doesn’t Weigh In on 340B Program

America First Policy Institute released a March 21 brief detailing how policymakers “could accelerate drug development and enhance patient health by implementing reforms that discourage other countries from freeloading off American drug innovation.”
A conservative think tank, which officials who served in President Donald Trump’s (R) first administration founded to advance his priorities, [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a
Read More »
×

*Sign up for news summaries and alerts from 340B Report

Site Footer Live